PB2149: MINIMAL RESIDUAL DISEASE (MRD) DETECTION TRENDING AS A PRIMARY ENDPOINT IN CERBA RESEARCH MULTIPLE MYELOMA (MM) TRIALS

Hemasphere · 2023 · PMC10429039

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

an observed trendno p-value reported

Additionally, MRD assessment has increasingly been incorporated as primary endpoint and surrogate to drug efficacy in CR MM trials with an observed trend.

also in 199 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.